(Q54373844)

28 May 2018

title

Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b. (English)

1 reference

28 May 2018

author name string

M Freund

1

1 reference

28 May 2018

P von Wussow

2

1 reference

28 May 2018

J Knüver-Hopf

3

1 reference

28 May 2018

H Mohr

4

1 reference

28 May 2018

U Pohl

5

1 reference

28 May 2018

G Exeriede

6

1 reference

28 May 2018

H Link

7

1 reference

28 May 2018

H J Wilke

8

1 reference

28 May 2018

H Poliwoda

9

1 reference

28 May 2018

publication date

1 November 1988

1 reference

28 May 2018

published in

Blut

1 reference

28 May 2018

volume

57

1 reference

28 May 2018

issue

5

1 reference

28 May 2018

page(s)

311-315

1 reference

28 May 2018

Interferon bioassay methods and the development of standard procedures: a critique and analysis of current observations

cites work

1 reference

12 December 2020

Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol)

1 reference

12 December 2020

A radioimmunologic technique to screen for antibodies to α-2 interferon

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

12 December 2020

Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection

1 reference

12 December 2020

Leucocyte-derived interferon-alpha in patients with antibodies to recombinant IFN-alpha 2b

1 reference

12 December 2020

Clinical investigation of human alpha interferon in chronic myelogenous leukemia.

1 reference

12 December 2020

Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells

1 reference

12 December 2020

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

12 December 2020

Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b.

1 reference

12 December 2020

Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoi

1 reference

12 December 2020

Is natural human leukocyte interferon still needed?

1 reference

12 December 2020

Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.

1 reference

12 December 2020

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1 reference

12 December 2020

Therapy of chronic myelogenous leukemia with recombinant interferon-gamma

1 reference

12 December 2020

Effect of interferon on pluripotent hemopoietic progenitors (CFU-GEMM) derived from human bone marrow

1 reference

12 December 2020

Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A)

1 reference

12 December 2020

Marrow transplantation for the treatment of chronic myelogenous leukemia

1 reference

12 December 2020

A rapid sensitive silver stain for polypeptides in polyacrylamide gels

1 reference

12 December 2020

Inhibitory Effects of Human Leukocyte and Fibroblast Interferons on Normal and Chronic Myelogenous Leukemic Granulocytic Progenitor Cells

1 reference

12 December 2020

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00320360

1 reference

28 May 2018

1 reference

28 May 2018